Clinical Trials Logo

Urinary Calculi clinical trials

View clinical trials related to Urinary Calculi.

Filter by:

NCT ID: NCT00857090 Completed - Kidney Stones Clinical Trials

Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones

Start date: March 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The objectives of the study are to assess the systemic exposure, safety and efficacy of three concentrations of OMS201 in subjects undergoing retrograde ureteroscopic removal of upper urinary tract stones.

NCT ID: NCT00637650 Completed - Urinary Stones Clinical Trials

Management of Fragments During Ureteroscopy

Start date: June 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to study the outcome of patients after ureteroscopy in which all fragments remaining after holmium laser lithotripsy were retrieved compared to those where small, insignificant fragments were left for spontaneous passage.

NCT ID: NCT00599664 Completed - Urinary Calculi Clinical Trials

Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones

Start date: December 2007
Phase: Phase 1
Study type: Interventional

Evaluate the safety and systemic absorption of OMS201 following exposure during ureteroscopy.

NCT ID: NCT00289120 Completed - Kidney Stone Clinical Trials

Effect of Cola on Urinary Stone Risk Factors

Start date: November 2003
Phase: N/A
Study type: Interventional

Examine the effects of cola on risks of kidney stones

NCT ID: NCT00199459 Completed - Urinary Calculi Clinical Trials

Proteomic Study of Urinary Stone Disease

Start date: January 2005
Phase: N/A
Study type: Observational

Urinary protein levels are not routinely measured in stone patients while there is strong evidence that proteins play a role in the etiology of stones. The purpose of this study is to examine the urinary and serum proteins of stone formers compared to healthy subjects utilizing the high throughput method, Surface Enhanced Laser Desorption/Ionization (SELDI). We hypothesize that there is a unique set of proteins expressed in serum and urine in stone patients that can be detected by SELDI. Ultimately, this will better our understanding of stone disease and help develop new prevention strategies.